[Federal Register Volume 72, Number 245 (Friday, December 21, 2007)]
[Notices]
[Pages 72770-72771]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E7-24870]


=======================================================================
-----------------------------------------------------------------------

OFFICE OF NATIONAL DRUG CONTROL POLICY


Paperwork Reduction Act; Notice of Intent To Collect; Comment 
Request

AGENCY: Office of National Drug Control Policy (ONDCP).

ACTION: ONDCP provides opportunity for public comment concerning the 
collection of information to identify the

[[Page 72771]]

Federal, State, and local resources assigned to drug control programs 
in our nation's largest cities.

-----------------------------------------------------------------------

SUMMARY: This action proposes the collection of drug control 
information from federal, state, and local governments.

SUPPLEMENTARY INFORMATION:

I. Background

    ONDCP previously collected information to establish a baseline of 
federal, state, and local drug control funding levels in the nation's 
largest metropolitan areas. The collection of this data will help ONDCP 
measure spending level changes, coordinate services, and develop 
National Drug Control Strategies.
    The project identifies in each affected city significant movements 
in key drug use measures, and encourages city administrators to use 
proven programs that increase efficiencies and effectiveness; promote 
coordination and collaboration; develop commitments; and, gather 
accurate performance measurement data.
    Type of Collection: Reinstatement with change of an approved data 
collection that expired.
    Title of Information Collection: Survey of drug treatment, drug use 
prevention, and law enforcement resources available to cities.
    Frequency: Annually by fiscal year.
    Affected Public: Instrumentalities of State, local, and tribal 
governments.
    Estimated Burden: Minimal since providers maintain the data for 
other purposes.

II. Special Issues for Comment

    ONDCP especially invites comments on: (a) Whether the proposed 
collection is necessary for the proper performance of ONDCP functions, 
including whether the information has practical utility; (b) ways to 
enhance information quality, utility, and clarity; and (c) ways to ease 
the burden on respondents, including the use of automated collection 
techniques or other forms of information technology.

ADDRESSES: Address all comments in writing within 60 days to Michael 
Reles. Facsimile and e-mail are the more reliable means of 
communication. Mr. Reles's facsimile number is (202) 395-5176, and his 
e-mail address is [email protected]. The Web site for the ONDCP is 
http://www.whitehousedrugpolicy.gov. Mailing address is Executive 
Office of the President, Office of National Drug Control Policy, 
Washington, DC 20503. For further information, contact Mr. Reles at 
(202) 395-6608.

    Signed at Washington DC on December 18, 2007.
Daniel R. Petersen,
Assistant General Counsel.
[FR Doc. E7-24870 Filed 12-20-07; 8:45 am]
BILLING CODE 3180-02-P